{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:06:21Z","timestamp":1790103981093,"version":"4.0.1"},"reference-count":92,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"The Deanship of Scientific Research (DSR) at King Abdulaziz University","award":["RG-15\u2013140-43"],"award-info":[{"award-number":["RG-15\u2013140-43"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/14756366.2026.2711875","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:39:28Z","timestamp":1787888368000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Exploration of novel hydroxamic acid-based candidates integrating chalcone scaffold cap as multitarget HDAC inhibitors: design, anti-prostatic cancer assessment,\n                    <i>in silico<\/i>\n                    docking and molecular dynamic simulation"],"prefix":"10.1080","volume":"41","author":[{"given":"Aya","family":"I. Abd El-hameed","sequence":"first","affiliation":[{"name":"Depatment of Pharmaceutical Chemistry, Faculty of Pharmacy, Sohag University","place":["Sohag, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim M.","family":"Salem","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Sphinx University","place":["New Assuit City, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha M.","family":"Allam","sequence":"additional","affiliation":[{"name":"Pharmacology Department, Medical and Clinical Research Institute, National Research Centre","place":["Dokki, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariem","family":"M. Arafat","sequence":"additional","affiliation":[{"name":"Cell Culture Unit, Life Science Division, Nawah-Scientific Inc","place":["Cairo, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossameldin A.","family":"Aziz","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, New Valley University","place":["Egypt"]},{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, New Valley National University","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuhier","family":"A. Awan","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek S.","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Faculty of Pharmacy, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Alshazly","sequence":"additional","affiliation":[{"name":"Depatment of Pharmaceutical Chemistry, Faculty of Pharmacy, Sohag University","place":["Sohag, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"A. M. Beshr","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, Faculty of Pharmacy, Minia University","place":["Egypt"]},{"name":"Medicinal Chemistry Department, Faculty of Pharmacy, Minia National University","place":["New Minia, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Br\u00e4se","sequence":"additional","affiliation":[{"name":"Institute for Biological and Chemical System, Karlsruhe Institute of Technology","place":["Karlsruhe, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7046-1799","authenticated-orcid":false,"given":"Mamdouh F. A.","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Depatment of Pharmaceutical Chemistry, Faculty of Pharmacy, Sohag University","place":["Sohag, Egypt"]},{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, New Valley University","place":["Egypt"]},{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, New Valley National University","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"issue":"6","key":"e_1_3_5_2_1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4161\/epi.3.6.7273","article-title":"The role of histone deacetylases in prostate cancer","volume":"3","author":"Abbas A","year":"2008","unstructured":"Abbas A, Gupta S. The role of histone deacetylases in prostate cancer. Epigenetics. 2008;3(6):300\u2013309.","journal-title":"Epigenetics"},{"issue":"2","key":"e_1_3_5_3_1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla P.","year":"2019","unstructured":"Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10(2):63\u201389.","journal-title":"World J Oncol"},{"issue":"2","key":"e_1_3_5_4_1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3390\/cancers15020461","article-title":"Metastatic prostate cancer\u2014a review of current treatment options and promising new approaches","volume":"15","author":"Posdzich P","year":"2023","unstructured":"Posdzich P, Darr C, Hilser T, Wahl M, Herrmann K, Hadaschik B, Gr\u00fcnwald V. Metastatic prostate cancer\u2014a review of current treatment options and promising new approaches. Cancers (Basel). 2023;15(2):461.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"e_1_3_5_5_1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12894-023-01179-9","article-title":"Skull metastasis is a poor prognostic factor for prostate cancer patients with bone metastasis: a retrospective study based on a Chinese population","volume":"23","author":"Xiong T","year":"2023","unstructured":"Xiong T, Jiang M, Ye X, Zhu G, Cao F, Cui Y, Yang M, Niu Y. Skull metastasis is a poor prognostic factor for prostate cancer patients with bone metastasis: a retrospective study based on a Chinese population. BMC Urol. 2023;23(1):13.","journal-title":"BMC Urol"},{"issue":"5","key":"e_1_3_5_6_1","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S0022-5347(17)38099-0","article-title":"Prostatic carcinosarcoma: case report and review of literature","volume":"146","author":"Nazeer T","year":"1991","unstructured":"Nazeer T, Barada JH, Fisher HA, Ross JS. Prostatic carcinosarcoma: case report and review of literature. J Urol. 1991;146(5):1370\u20131373.","journal-title":"J Urol"},{"issue":"2","key":"e_1_3_5_7_1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3390\/biomedicines11020633","article-title":"Oncogenic long noncoding RNAs in prostate cancer, osteosarcoma, and metastasis","volume":"11","author":"Al-Shehri A","year":"2023","unstructured":"Al-Shehri A, Bakhashab S. Oncogenic long noncoding RNAs in prostate cancer, osteosarcoma, and metastasis. Biomedicines. 2023;11(2):633.","journal-title":"Biomedicines"},{"issue":"3","key":"e_1_3_5_8_1","first-page":"1193","article-title":"New roles of osteocytes in proliferation, migration and invasion of breast and prostate cancer cells","volume":"36","author":"Cui YX","year":"2016","unstructured":"Cui YX, Evans BA, Jiang WG. New roles of osteocytes in proliferation, migration and invasion of breast and prostate cancer cells. Anticancer Res. 2016;36(3):1193\u20131201.","journal-title":"Anticancer Res"},{"key":"e_1_3_5_9_1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.semcancer.2022.10.006","article-title":"Mechanisms of cancer metastasis","volume":"87","author":"Castaneda M","year":"2022","unstructured":"Castaneda M, den Hollander P, Kuburich NA, Rosen JM, Mani SA. Mechanisms of cancer metastasis. Semin Cancer Biol. 2022;87:17\u201331.","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"e_1_3_5_10_1","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/ijc.33673","article-title":"International trends in incidence of osteosarcoma (1988-2012)","volume":"149","author":"Rojas GA","year":"2021","unstructured":"Rojas GA, Hubbard AK, Diessner BJ, Ribeiro KB, Spector LG. International trends in incidence of osteosarcoma (1988-2012). Int J Cancer. 2021;149(5):1044\u20131053.","journal-title":"Int J Cancer"},{"key":"e_1_3_5_11_1","doi-asserted-by":"crossref","first-page":"100039","DOI":"10.1016\/j.adcanc.2022.100039","article-title":"Role of various non-coding RNAs in EMT, cancer, and metastasis: recent trends and future perspective","volume":"4","author":"Singh A","year":"2022","unstructured":"Singh A, Malvankar S, Ravi Kumar YS, Seervi M, Srivastava RK, Verma B. Role of various non-coding RNAs in EMT, cancer, and metastasis: recent trends and future perspective. Adv Cancer Biol Metastasis. 2022;4:100039.","journal-title":"Adv Cancer Biol Metastasis"},{"issue":"3","key":"e_1_3_5_12_1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4111\/icu.20230026","article-title":"Animal models of bone metastatic prostate cancer","volume":"64","author":"Tae JH","year":"2023","unstructured":"Tae JH, Chang IH. Animal models of bone metastatic prostate cancer. Investig Clin Urol. 2023;64(3):219\u2013228.","journal-title":"Investig Clin Urol"},{"issue":"3","key":"e_1_3_5_13_1","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41391-023-00679-x","article-title":"Characterisation of cell lines derived from prostate cancer patients with localised disease","volume":"26","author":"Moya L","year":"2023","unstructured":"Moya L, Walpole C, Rae F, Srinivasan S, Seim I, Lai J, Nicol D, Williams ED, Clements JA, Batra J. Characterisation of cell lines derived from prostate cancer patients with localised disease. Prostate Cancer Prostatic Dis. 2023;26(3):614\u2013624.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"9","key":"e_1_3_5_14_1","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.3390\/cancers12092651","article-title":"Cellular and molecular progression of prostate cancer: models for basic and preclinical research","volume":"12","author":"Saranyutanon S","year":"2020","unstructured":"Saranyutanon S, Deshmukh SK, Dasgupta S, Pai S, Singh S, Singh AP. Cellular and molecular progression of prostate cancer: models for basic and preclinical research. Cancers (Basel). 2020;12(9):2651.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"e_1_3_5_15_1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrd2089","article-title":"Strategies for optimizing combinations of molecularly targeted anticancer agents","volume":"5","author":"Dancey JE","year":"2006","unstructured":"Dancey JE, Chen HX. Strategies for optimizing combinations of molecularly targeted anticancer agents. Nat Rev Drug Discov. 2006;5(8):649\u2013659.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"e_1_3_5_16_1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrd1930","article-title":"Epigenetic therapy of cancer: past, present and future","volume":"5","author":"Yoo CB","year":"2006","unstructured":"Yoo CB, Jones PA. Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov. 2006;5(1):37\u201350.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"e_1_3_5_17_1","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1038\/s41467-024-49784-y","article-title":"Epigenetic-based differentiation therapy for Acute Myeloid Leukemia","volume":"15","author":"San Jos\u00e9-En\u00e9riz E","year":"2024","unstructured":"San Jos\u00e9-En\u00e9riz E, Gimenez-Camino N, Rabal O, Garate L, Miranda E, G\u00f3mez-Echarte N, Garc\u00eda F, Charalampopoulou S, S\u00e1ez E, Vilas-Zornoza A, et al. Epigenetic-based differentiation therapy for Acute Myeloid Leukemia. Nat Commun. 2024;15(1):5570.","journal-title":"Nat Commun"},{"issue":"10","key":"e_1_3_5_18_1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41577-018-0037-z","article-title":"Histone deacetylase function in CD4+ T cells","volume":"18","author":"Ellmeier W","year":"2018","unstructured":"Ellmeier W, Seiser C. Histone deacetylase function in CD4+ T cells. Nat Rev Immunol. 2018;18(10):617\u2013634.","journal-title":"Nat Rev Immunol"},{"issue":"5532","key":"e_1_3_5_19_1","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1063127","article-title":"Translating the histone code","volume":"293","author":"Jenuwein T","year":"2001","unstructured":"Jenuwein T, Allis CD. Translating the histone code. Science. 2001;293(5532):1074\u20131080.","journal-title":"Science"},{"key":"e_1_3_5_20_1","doi-asserted-by":"crossref","first-page":"103127","DOI":"10.1016\/j.bioorg.2019.103127","article-title":"Utilization of tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidinone as a cap moiety in design of novel histone deacetylase inhibitors","volume":"91","author":"Mohamed MFA","year":"2019","unstructured":"Mohamed MFA, Youssif BGM, Shaykoon MSA, Abdelrahman MH, Elsadek BEM, Aboraia AS, Abuo-Rahma GE-DA. Utilization of tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidinone as a cap moiety in design of novel histone deacetylase inhibitors. Bioorg Chem. 2019;91:103127.","journal-title":"Bioorg Chem"},{"issue":"9","key":"e_1_3_5_21_1","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden JE","year":"2006","unstructured":"Bolden JE, Peart MJ, Johnstone RW. Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov. 2006;5(9):769\u2013784.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"e_1_3_5_22_1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/ncponc0106","article-title":"Drug Insight: histone deacetylase inhibitors\u2014development of the new targeted anticancer agent suberoylanilide hydroxamic acid","volume":"2","author":"Kelly WK","year":"2005","unstructured":"Kelly WK, Marks PA. Drug Insight: histone deacetylase inhibitors\u2014development of the new targeted anticancer agent suberoylanilide hydroxamic acid. Nat Clin Pract Oncol. 2005;2(3):150\u2013157.","journal-title":"Nat Clin Pract Oncol"},{"issue":"1","key":"e_1_3_5_23_1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","article-title":"Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer","volume":"6","author":"Minucci S","year":"2006","unstructured":"Minucci S, Pelicci PG. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer. 2006;6(1):38\u201351.","journal-title":"Nat Rev Cancer"},{"key":"e_1_3_5_24_1","doi-asserted-by":"crossref","first-page":"103797","DOI":"10.1016\/j.bioorg.2020.103797","article-title":"Design, synthesis and anticancer activity of novel valproic acid conjugates with improved histone deacetylase (HDAC) inhibitory activity","volume":"99","author":"Ibrahim TS","year":"2020","unstructured":"Ibrahim TS, Sheha TA, Abo-Dya NE, AlAwadh MA, Alhakamy NA, Abdel-Samii ZK, Panda SS, Abuo-Rahma GE-DA, Mohamed MFA. Design, synthesis and anticancer activity of novel valproic acid conjugates with improved histone deacetylase (HDAC) inhibitory activity. Bioorg Chem. 2020;99:103797.","journal-title":"Bioorg Chem"},{"key":"e_1_3_5_25_1","doi-asserted-by":"crossref","first-page":"105564","DOI":"10.1016\/j.bioorg.2021.105564","article-title":"Utilization of cyanopyridine in design and synthesis of first-in-class anticancer dual acting PIM-1 kinase\/HDAC inhibitors","volume":"119","author":"Bass AKA","year":"2022","unstructured":"Bass AKA, Nageeb E-SM, El-Zoghbi MS, Mohamed MFA, Badr M, Abuo-Rahma GE-DA. Utilization of cyanopyridine in design and synthesis of first-in-class anticancer dual acting PIM-1 kinase\/HDAC inhibitors. Bioorg Chem. 2022;119:105564.","journal-title":"Bioorg Chem"},{"issue":"12","key":"e_1_3_5_26_1","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1021\/acs.chemrev.7b00020","article-title":"Chalcone: a privileged structure in medicinal chemistry","volume":"117","author":"Zhuang C","year":"2017","unstructured":"Zhuang C, Zhang W, Sheng C, Zhang W, Xing C, Miao Z. Chalcone: a privileged structure in medicinal chemistry. Chem Rev. 2017;117(12):7762\u20137810.","journal-title":"Chem Rev"},{"key":"e_1_3_5_27_1","doi-asserted-by":"crossref","first-page":"104885","DOI":"10.1016\/j.bioorg.2021.104885","article-title":"Novel 1,2,4-oxadiazole-chalcone\/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study","volume":"111","author":"Ibrahim TS","year":"2021","unstructured":"Ibrahim TS, Almalki AJ, Moustafa AH, Allam RM, Abuo-Rahma GE-DA, El Subbagh HI, Mohamed MFA. Novel 1,2,4-oxadiazole-chalcone\/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study. Bioorg Chem. 2021;111:104885.","journal-title":"Bioorg Chem"},{"issue":"1","key":"e_1_3_5_28_1","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1080\/14756366.2021.1929201","article-title":"Novel chalcone\/aryl carboximidamide hybrids as potent anti-inflammatory via inhibition of prostaglandin E2 and inducible NO synthase activities: design, synthesis, molecular docking studies and ADMET prediction","volume":"36","author":"Ibrahim TS","year":"2021","unstructured":"Ibrahim TS, Moustafa AH, Almalki AJ, Allam RM, Althagafi A, Md S, Mohamed MFA. Novel chalcone\/aryl carboximidamide hybrids as potent anti-inflammatory via inhibition of prostaglandin E2 and inducible NO synthase activities: design, synthesis, molecular docking studies and ADMET prediction. J Enzyme Inhib Med Chem. 2021;36(1):1067\u20131078.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"e_1_3_5_29_1","doi-asserted-by":"crossref","first-page":"142578","DOI":"10.1016\/j.molstruc.2025.142578","article-title":"Design, synthesis and biological evaluation of phenoxyacetic acid derivatives linked to pyrazole scaffold as PPAR-\u03b1\/\u03b3 Agonists and COX-2 inhibitors with dual antidiabetic\/anti-inflammatory activities","volume":"1340","author":"Fadaly WAA","year":"2025","unstructured":"Fadaly WAA, Amin DME, Bakr RB, Nemr MTM, Ismail BS, Mohamed MFA. Design, synthesis and biological evaluation of phenoxyacetic acid derivatives linked to pyrazole scaffold as PPAR-\u03b1\/\u03b3 Agonists and COX-2 inhibitors with dual antidiabetic\/anti-inflammatory activities. J Mol Struct. 2025;1340:142578.","journal-title":"J Mol Struct"},{"key":"e_1_3_5_30_1","doi-asserted-by":"crossref","first-page":"108540","DOI":"10.1016\/j.bioorg.2025.108540","article-title":"Novel chalcone candidates as potential in vitro and in vivo anti-inflammatory agents: Synthesis, in silico docking, multitarget bioevaluation and molecular dynamic simulation","volume":"161","author":"Ahmed AKM","year":"2025","unstructured":"Ahmed AKM, Beshr EAM, Salem IM, Ahmed OAA, Ibrahim TS, Elsayed Abouzed DE, Mahmoud AM, Mohamed MFA. Novel chalcone candidates as potential in vitro and in vivo anti-inflammatory agents: Synthesis, in silico docking, multitarget bioevaluation and molecular dynamic simulation. Bioorg Chem. 2025;161:108540.","journal-title":"Bioorg Chem"},{"issue":"24","key":"e_1_3_5_31_1","doi-asserted-by":"crossref","first-page":"19043","DOI":"10.1039\/D5RA00834D","article-title":"Amide linked chalcone derivatives, a promising class of compounds with versatile biological effects","volume":"15","author":"Alshazly O","year":"2025","unstructured":"Alshazly O, Abuo-Rahma GE-DA, Mohamed MF, Abdel-Aziz M. Amide linked chalcone derivatives, a promising class of compounds with versatile biological effects. RSC Adv. 2025;15(24):19043\u201319068.","journal-title":"RSC Adv"},{"issue":"52","key":"e_1_3_5_32_1","doi-asserted-by":"crossref","first-page":"31139","DOI":"10.1039\/D0RA05594H","article-title":"Molecular targets and anticancer activity of quinoline\u2013chalcone hybrids: literature review","volume":"10","author":"Mohamed MFA","year":"2020","unstructured":"Mohamed MFA, Abuo-Rahma GE-DA. Molecular targets and anticancer activity of quinoline\u2013chalcone hybrids: literature review. RSC Adv. 2020;10(52):31139\u201331155.","journal-title":"RSC Adv"},{"key":"e_1_3_5_33_1","doi-asserted-by":"crossref","first-page":"102997","DOI":"10.1016\/j.bioorg.2019.102997","article-title":"EGFR inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and docking studies of novel xanthine derivatives carrying chalcone moiety as hybrid molecules","volume":"89","author":"Abou-Zied HA","year":"2019","unstructured":"Abou-Zied HA, Youssif BGM, Mohamed MFA, Hayallah AM, Abdel-Aziz M. EGFR inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and docking studies of novel xanthine derivatives carrying chalcone moiety as hybrid molecules. Bioorg Chem. 2019;89:102997.","journal-title":"Bioorg Chem"},{"key":"e_1_3_5_34_1","doi-asserted-by":"crossref","first-page":"106171","DOI":"10.1016\/j.bioorg.2022.106171","article-title":"Design, synthesis, and molecular docking of novel pyrazole-chalcone analogs of lonazolac as 5-LOX, iNOS and tubulin polymerization inhibitors with potential anticancer and anti-inflammatory activities","volume":"129","author":"Ahmed AHH","year":"2022","unstructured":"Ahmed AHH, Mohamed MFA, Allam RM, Nafady A, Mohamed SK, Gouda AE, Beshr EAM. Design, synthesis, and molecular docking of novel pyrazole-chalcone analogs of lonazolac as 5-LOX, iNOS and tubulin polymerization inhibitors with potential anticancer and anti-inflammatory activities. Bioorg Chem. 2022;129:106171.","journal-title":"Bioorg Chem"},{"issue":"3","key":"e_1_3_5_35_1","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1007\/s11030-025-11411-3","article-title":"Novel pyrazole\u2013oxadiazole\u2013chalcone\/oxime \u00adhybrids as dual EGFR\/VEGFR-2 inhibitors with promising anticancer potential: a comprehensive cytotoxicity evaluation, mechanistic insights and SAR analysis","volume":"30","author":"Alshazly O","year":"2026","unstructured":"Alshazly O, Abdel-Aziz M, Abuo-Rahma GE-DA, Mohamed MF. Novel pyrazole\u2013oxadiazole\u2013chalcone\/oxime \u00adhybrids as dual EGFR\/VEGFR-2 inhibitors with promising anticancer potential: a comprehensive cytotoxicity evaluation, mechanistic insights and SAR analysis. Mol Divers. 2026;30(3):4667\u20134699.","journal-title":"Mol Divers"},{"key":"e_1_3_5_36_1","first-page":"448","article-title":"In vitro and in vivo anticancer studies of 2\u2019-hydroxy chalcone derivatives exhibit apoptosis in colon cancer cells by HDAC inhibition and cell cycle arrest","volume":"16","author":"Pande AN","year":"2017","unstructured":"Pande AN, Biswas S, Reddy ND, Jayashree B, Kumar N, Rao CM. In vitro and in vivo anticancer studies of 2\u2019-hydroxy chalcone derivatives exhibit apoptosis in colon cancer cells by HDAC inhibition and cell cycle arrest. Excli J. 2017;16:448.","journal-title":"Excli J"},{"key":"e_1_3_5_37_1","doi-asserted-by":"crossref","first-page":"137749","DOI":"10.1016\/j.molstruc.2024.137749","article-title":"Design, synthesis, biological evaluation and molecular docking study of novel chalcone-based hydroxamic acids possessing a central 2, 4-dimethy pyrrole linker as potential HDAC (Histone Deacetylase) inhibitors and anticancer agents","volume":"1305","author":"Yousefian M","year":"2024","unstructured":"Yousefian M, Hashemi M, Eskandarpour V, Hadizadeh F, Zarghi A, Ghodsi R. Design, synthesis, biological evaluation and molecular docking study of novel chalcone-based hydroxamic acids possessing a central 2, 4-dimethy pyrrole linker as potential HDAC (Histone Deacetylase) inhibitors and anticancer agents. J Mol Struct. 2024;1305:137749.","journal-title":"J Mol Struct"},{"key":"e_1_3_5_38_1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bioorg.2017.03.005","article-title":"Design, synthesis, docking studies and biological evaluation of novel chalcone derivatives as potential histone deacetylase inhibitors","volume":"72","author":"Mohamed MFA","year":"2017","unstructured":"Mohamed MFA, Shaykoon MSA, Abdelrahman MH, Elsadek BEM, Aboraia AS, Abuo-Rahma G. Design, synthesis, docking studies and biological evaluation of novel chalcone derivatives as potential histone deacetylase inhibitors. Bioorg Chem. 2017;72:32\u201341.","journal-title":"Bioorg Chem"},{"issue":"11","key":"e_1_3_5_39_1","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3390\/ph14111177","article-title":"Design, synthesis, in vitro anticancer evaluation and molecular modelling studies of 3,4,5-trimethoxyphenyl-based derivatives as dual EGFR\/HDAC hybrid inhibitors","volume":"14","author":"Ibrahim TS","year":"2021","unstructured":"Ibrahim TS, Malebari AM, Mohamed MFA. Design, synthesis, in vitro anticancer evaluation and molecular modelling studies of 3,4,5-trimethoxyphenyl-based derivatives as dual EGFR\/HDAC hybrid inhibitors. Pharmaceuticals. 2021;14(11):1177.","journal-title":"Pharmaceuticals"},{"key":"e_1_3_5_40_1","doi-asserted-by":"crossref","first-page":"105454","DOI":"10.1016\/j.jff.2023.105454","article-title":"The anti-tumor activities of coenzyme Q0 through ROS-mediated autophagic cell death in human triple-negative breast cells","volume":"102","author":"Yang H-L","year":"2023","unstructured":"Yang H-L, Huang S-T, Lyu Z-H, Bhat AA, Vadivalagan C, Yeh Y-L, Hseu Y-C. The anti-tumor activities of coenzyme Q0 through ROS-mediated autophagic cell death in human triple-negative breast cells. J Funct Foods. 2023;102:105454.","journal-title":"J Funct Foods"},{"key":"e_1_3_5_41_1","doi-asserted-by":"crossref","unstructured":"Rudzinski JK Govindasamy NP Lewis JD Jurasz P. the role of the androgen receptor in prostate cancer-induced platelet aggregation and platelet-induced invasion. Journal of thrombosis and haemostasis. 2020;18(11):2976\u20132986. [Mismatch","DOI":"10.1111\/jth.15020"},{"issue":"9","key":"e_1_3_5_42_1","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.7150\/thno.92119","article-title":"A novel selenium analog of HDACi-based twin drug induces apoptosis and cell cycle arrest via CDC25A to improve prostate cancer therapy","volume":"14","author":"Shi Z","year":"2024","unstructured":"Shi Z, Liu M, Zhang X, Wang J, Zhang J, Peng Z, Meng L, Wang R, Guo L, Zhang Q, et al. A novel selenium analog of HDACi-based twin drug induces apoptosis and cell cycle arrest via CDC25A to improve prostate cancer therapy. Theranostics. 2024;14(9):3565\u20133582.","journal-title":"Theranostics"},{"key":"e_1_3_5_43_1","doi-asserted-by":"crossref","first-page":"1529239","DOI":"10.3389\/fimmu.2025.1529239","article-title":"Mechanisms of HDACs in cancer development","volume":"16","author":"Zhang Y","year":"2025","unstructured":"Zhang Y, Wang H, Zhan Z, Gan L, Bai O. Mechanisms of HDACs in cancer development. Front Immunol. 2025;16:1529239.","journal-title":"Front Immunol"},{"issue":"1","key":"e_1_3_5_44_1","doi-asserted-by":"crossref","first-page":"24589","DOI":"10.1038\/s41598-025-08474-5","article-title":"Design and synthesis of thiazole-based hydroxamate histone deacetylase inhibitors with potent antitumor efficacy by inducing apoptosis, pyroptosis and cell cycle arrest","volume":"15","author":"Li Z","year":"2025","unstructured":"Li Z, Qiu H, Lu W, Duan N, Fan S, Zhou R, Li X, Zhang H, Liu N, Yang F. Design and synthesis of thiazole-based hydroxamate histone deacetylase inhibitors with potent antitumor efficacy by inducing apoptosis, pyroptosis and cell cycle arrest. Sci Rep. 2025;15(1):24589.","journal-title":"Sci Rep"},{"issue":"6","key":"e_1_3_5_45_1","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3390\/ph17060752","article-title":"Novel histone deacetylase (HDAC) inhibitor induces apoptosis and suppresses invasion via E-cadherin upregulation in pancreatic ductal adenocarcinoma (PDAC)","volume":"17","author":"Schiedlauske K","year":"2024","unstructured":"Schiedlauske K, Deipenbrock A, Pflieger M, Hamacher A, H\u00e4nsel J, Kassack MU, Kurz T, Teusch NE. Novel histone deacetylase (HDAC) inhibitor induces apoptosis and suppresses invasion via E-cadherin upregulation in pancreatic ductal adenocarcinoma (PDAC). Pharmaceuticals. 2024;17(6):752.","journal-title":"Pharmaceuticals"},{"issue":"14","key":"e_1_3_5_46_1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23147981","article-title":"Mechanism-based sonodynamic-chemo combinations against triple-negative breast cancer","volume":"23","author":"Feng X","year":"2022","unstructured":"Feng X, Wu C, Yang W, Wu J, Wang P. Mechanism-based sonodynamic-chemo combinations against triple-negative breast cancer. Int J Mol Sci. 2022;23(14):7981","journal-title":"Int J Mol Sci"},{"issue":"13","key":"e_1_3_5_47_1","article-title":"The influence of cell cycle regulation on chemotherapy","volume":"22","author":"Sun Y","year":"2021","unstructured":"Sun Y, Liu Y, Ma X, Hu H. The influence of cell cycle regulation on chemotherapy. Int J Mol Sci. 2021;22(13) 6923.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_5_48_1","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2147\/DDDT.S156826","article-title":"Inhibition of human prostate cancer (PC-3) cells and targeting of PC-3-derived prostate cancer stem cells with koenimbin, a natural dietary compound from Murraya koenigii (L) Spreng","volume":"12","author":"Kamalidehghan B","year":"2018","unstructured":"Kamalidehghan B, Ghafouri-Fard S, Motevaseli E, Ahmadipour F. Inhibition of human prostate cancer (PC-3) cells and targeting of PC-3-derived prostate cancer stem cells with koenimbin, a natural dietary compound from Murraya koenigii (L) Spreng. Drug Des Devel Ther. 2018;12:1119\u20131133.","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"e_1_3_5_49_1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40164-024-00507-5","article-title":"Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives","volume":"13","author":"Pu J","year":"2024","unstructured":"Pu J, Liu T, Wang X, Sharma A, Schmidt-Wolf IGH, Jiang L, Hou J. Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives. Exp Hematol Oncol. 2024;13(1):45.","journal-title":"Exp Hematol Oncol"},{"issue":"18","key":"e_1_3_5_50_1","doi-asserted-by":"crossref","first-page":"9966","DOI":"10.3390\/ijms22189966","article-title":"Growth, proliferation and metastasis of prostate cancer cells is blocked by low-dose curcumin in combination with light irradiation","volume":"22","author":"Rutz J","year":"2021","unstructured":"Rutz J, Benchellal A, Kassabra W, Maxeiner S, Bernd A, Kippenberger S, Z\u00f6ller N, Chun FK, Juengel E, Blaheta RA. Growth, proliferation and metastasis of prostate cancer cells is blocked by low-dose curcumin in combination with light irradiation. Int J Mol Sci. 2021;22(18):9966.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"e_1_3_5_51_1","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1158\/1535-7163.MCT-04-0288","article-title":"Discovery and preclinical evaluation of a novel class of small-molecule compounds in hormone-dependent and -independent cancer cell lines","volume":"4","author":"Plasencia C","year":"2005","unstructured":"Plasencia C, Dayam R, Wang Q, Pinski J, Burke TR, Jr., Quinn DI, Neamati N. Discovery and preclinical evaluation of a novel class of small-molecule compounds in hormone-dependent and -independent cancer cell lines. Mol Cancer Ther. 2005;4(7):1105\u20131113.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"e_1_3_5_52_1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s40001-025-02401-0","article-title":"Anticancer efficacy of Spiruchostatin A: current insights into histone deacetylase inhibition and oncologic applications","volume":"30","author":"Ibrahim S","year":"2025","unstructured":"Ibrahim S, Khan MU, Khurram I, Ghani MU, Sharifi-Rad J, Calina D. Anticancer efficacy of Spiruchostatin A: current insights into histone deacetylase inhibition and oncologic applications. Eur J Med Res. 2025;30(1):169.","journal-title":"Eur J Med Res"},{"key":"e_1_3_5_53_1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jep.2015.03.048","article-title":"Glycosmis pentaphylla (Retz.) DC arrests cell cycle and induces apoptosis via caspase-3\/7 activation in breast cancer cells","volume":"168","author":"Shoja MH","year":"2015","unstructured":"Shoja MH, Reddy ND, Nayak PG, Srinivasan KK, Rao CM. Glycosmis pentaphylla (Retz.) DC arrests cell cycle and induces apoptosis via caspase-3\/7 activation in breast cancer cells. J Ethnopharmacol. 2015;168:50\u201360.","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"e_1_3_5_54_1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.canlet.2014.12.003","article-title":"Mutations of p53 and KRAS activate NF-\u03baB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells","volume":"357","author":"Yang L","year":"2015","unstructured":"Yang L, Zhou Y, Li Y, Zhou J, Wu Y, Cui Y, Yang G, Hong Y. Mutations of p53 and KRAS activate NF-\u03baB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells. Cancer Lett. 2015;357(2):520\u2013526.","journal-title":"Cancer Lett"},{"issue":"20","key":"e_1_3_5_55_1","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1007\/s00018-014-1656-6","article-title":"Histone deacetylase inhibitors and cell death","volume":"71","author":"Zhang J","year":"2014","unstructured":"Zhang J, Zhong Q. Histone deacetylase inhibitors and cell death. Cell Mol Life Sci. 2014;71(20):3885\u20133901.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"e_1_3_5_56_1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.seminoncol.2003.11.006","article-title":"Apoptosis in cancer\u2013implications for therapy","volume":"31","author":"Schulze-Bergkamen H","year":"2004","unstructured":"Schulze-Bergkamen H, Krammer PH. Apoptosis in cancer\u2013implications for therapy. Semin Oncol. 2004;31(1):90\u2013119.","journal-title":"Semin Oncol"},{"issue":"1","key":"e_1_3_5_57_1","doi-asserted-by":"crossref","first-page":"15798","DOI":"10.1038\/srep15798","article-title":"Doxorubicin-induced necrosis is mediated by poly-(ADP-ribose) polymerase 1 (PARP1) but is independent of p53","volume":"5","author":"Shin H-J","year":"2015","unstructured":"Shin H-J, Kwon H-K, Lee J-H, Gui X, Achek A, Kim J-H, Choi S. Doxorubicin-induced necrosis is mediated by poly-(ADP-ribose) polymerase 1 (PARP1) but is independent of p53. Sci Rep. 2015;5(1):15798.","journal-title":"Sci Rep"},{"issue":"7","key":"e_1_3_5_58_1","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41419-022-05066-3","article-title":"Regulated necrosis, a proinflammatory cell death, potentially counteracts pathogenic infections","volume":"13","author":"Zhang G","year":"2022","unstructured":"Zhang G, Wang J, Zhao Z, Xin T, Fan X, Shen Q, Raheem A, Lee CR, Jiang H, Ding J. Regulated necrosis, a proinflammatory cell death, potentially counteracts pathogenic infections. Cell Death Dis. 2022;13(7):637.","journal-title":"Cell Death Dis"},{"issue":"1","key":"e_1_3_5_59_1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s13046-019-1267-z","article-title":"p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition","volume":"38","author":"Aggarwal M","year":"2019","unstructured":"Aggarwal M, Saxena R, Asif N, Sinclair E, Tan J, Cruz I, Berry D, Kallakury B, Pham Q, Wang TTY, et al. p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition. J Exp Clin Cancer Res. 2019;38(1):307.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"e_1_3_5_60_1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41416-020-01149-0","article-title":"Mutational drivers of cancer cell migration and invasion","volume":"124","author":"Novikov NM","year":"2021","unstructured":"Novikov NM, Zolotaryova SY, Gautreau AM, Denisov EV. Mutational drivers of cancer cell migration and invasion. Br J Cancer. 2021;124(1):102\u2013114.","journal-title":"Br J Cancer"},{"issue":"10","key":"e_1_3_5_61_1","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.3390\/cancers15102758","article-title":"Inhibitory potential of resveratrol in cancer metastasis: from biology to therapy","volume":"15","author":"Song B","year":"2023","unstructured":"Song B, Wang W, Tang X, Goh RMW, Thuya WL, Ho PCL, Chen L, Wang L. Inhibitory potential of resveratrol in cancer metastasis: from biology to therapy. Cancers (Basel). 2023;15(10):2758.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"e_1_3_5_62_1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00018-022-04665-9","article-title":"Aquaporin-mediated dysregulation of cell migration in disease states","volume":"80","author":"Smith IM","year":"2023","unstructured":"Smith IM, Banerjee S, Moses AK, Stroka KM. Aquaporin-mediated dysregulation of cell migration in disease states. Cell Mol Life Sci. 2023;80(2):48.","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"e_1_3_5_63_1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.31557\/apjcb.2024.9.3.271-281","article-title":"Decursin inhibits expression and nuclear localization of dnmt and hdac, and suppresses the growth and survival of prostate cancer cells","volume":"9","author":"Dwivedi L","year":"2024","unstructured":"Dwivedi L, Jaiswal A, Punia R, Kumar RS, Yim D, Rajamani P, Singh R. Decursin inhibits expression and nuclear localization of dnmt and hdac, and suppresses the growth and survival of prostate cancer cells. Asian Pac J Cancer Biol. 2024;9(3):271\u2013281.","journal-title":"Asian Pac J Cancer Biol"},{"key":"e_1_3_5_64_1","doi-asserted-by":"crossref","first-page":"109489","DOI":"10.1016\/j.abb.2022.109489","article-title":"Anti-proliferative, pro-apototic and anti-migratory properties of HDAC inhibitor PXD-101 on osteosarcoma cell lines","volume":"734","author":"Rossi M","year":"2023","unstructured":"Rossi M, De Martino V, Di Giuseppe L, Battafarano G, Di Gregorio J, Terreri S, Marampon F, Minisola S, Del Fattore A. Anti-proliferative, pro-apototic and anti-migratory properties of HDAC inhibitor PXD-101 on osteosarcoma cell lines. Arch Biochem Biophys. 2023;734:109489.","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"e_1_3_5_65_1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2007.10.039","article-title":"New nomenclature for chromatin-modifying enzymes","volume":"131","author":"Allis CD","year":"2007","unstructured":"Allis CD, Berger SL, Cote J, Dent S, Jenuwien T, Kouzarides T, Pillus L, Reinberg D, Shi Y, Shiekhattar R, et al. New nomenclature for chromatin-modifying enzymes. Cell. 2007;131(4):633\u2013636.","journal-title":"Cell"},{"issue":"37","key":"e_1_3_5_66_1","doi-asserted-by":"crossref","first-page":"26926","DOI":"10.1074\/jbc.M113.490706","article-title":"Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viability","volume":"288","author":"Lauffer BEL","year":"2013","unstructured":"Lauffer BEL, Mintzer R, Fong R, Mukund S, Tam C, Zilberleyb I, Flicke B, Ritscher A, Fedorowicz G, Vallero R, et al. Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viability. J Biol Chem. 2013;288(37):26926\u201326943.","journal-title":"J Biol Chem"},{"issue":"9","key":"e_1_3_5_67_1","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1111\/j.1582-4934.2011.01321.x","article-title":"Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis","volume":"15","author":"Clocchiatti A","year":"2011","unstructured":"Clocchiatti A, Florean C, Brancolini C. Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis. J Cell Mol Med. 2011;15(9):1833\u20131846.","journal-title":"J Cell Mol Med"},{"issue":"44","key":"e_1_3_5_68_1","doi-asserted-by":"crossref","first-page":"29483","DOI":"10.1039\/C5CP05633K","article-title":"Inhibition mechanism of SAHA in HDAC: a revisit","volume":"17","author":"Zhou J","year":"2015","unstructured":"Zhou J, Wu R, Luo H-B. Inhibition mechanism of SAHA in HDAC: a revisit. Phys Chem Chem Phys. 2015;17(44):29483\u201329488.","journal-title":"Phys Chem Chem Phys"},{"issue":"24","key":"e_1_3_5_69_1","doi-asserted-by":"crossref","first-page":"9934","DOI":"10.1021\/jm4011884","article-title":"Design, synthesis, and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for Huntington\u2019s disease","volume":"56","author":"B\u00fcrli RW","year":"2013","unstructured":"B\u00fcrli RW, Luckhurst CA, Aziz O, Matthews KL, Yates D, Lyons KA, Beconi M, McAllister G, Breccia P, Stott AJ, et al. Design, synthesis, and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for Huntington\u2019s disease. J Med Chem. 2013;56(24):9934\u20139954.","journal-title":"J Med Chem"},{"issue":"5","key":"e_1_3_5_70_1","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s13402-022-00704-6","article-title":"HDAC6: A unique HDAC family member as a cancer target","volume":"45","author":"Kaur S","year":"2022","unstructured":"Kaur S, Rajoria P, Chopra M. HDAC6: A unique HDAC family member as a cancer target. Cell Oncol (Dordr). 2022;45(5):779\u2013829.","journal-title":"Cell Oncol (Dordr)"},{"issue":"4","key":"e_1_3_5_71_1","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1074\/jbc.M111.273730","article-title":"Protein aggregates are recruited to aggresome by histone deacetylase 6 via unanchored ubiquitin C termini","volume":"287","author":"Ouyang H","year":"2012","unstructured":"Ouyang H, Ali YO, Ravichandran M, Dong A, Qiu W, MacKenzie F, Dhe-Paganon S, Arrowsmith CH, Zhai RG. Protein aggregates are recruited to aggresome by histone deacetylase 6 via unanchored ubiquitin C termini. J Biol Chem. 2012;287(4):2317\u20132327.","journal-title":"J Biol Chem"},{"issue":"7","key":"e_1_3_5_72_1","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1039\/b703830p","article-title":"Isoform-selective histone deacetylase inhibitors","volume":"37","author":"Bieliauskas AV","year":"2008","unstructured":"Bieliauskas AV, Pflum MKH. Isoform-selective histone deacetylase inhibitors. Chem Soc Rev. 2008;37(7):1402\u20131413.","journal-title":"Chem Soc Rev"},{"issue":"9","key":"e_1_3_5_73_1","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1016\/j.bmcl.2011.01.134","article-title":"Discovery of histone deacetylase 8 selective inhibitors","volume":"21","author":"Tang W","year":"2011","unstructured":"Tang W, Luo T, Greenberg EF, Bradner JE, Schreiber SL. Discovery of histone deacetylase 8 selective inhibitors. Bioorg Med Chem Lett. 2011;21(9):2601\u20132605.","journal-title":"Bioorg Med Chem Lett"},{"issue":"15","key":"e_1_3_5_74_1","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1016\/j.bmc.2011.06.030","article-title":"Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors","volume":"19","author":"Whitehead L","year":"2011","unstructured":"Whitehead L, Dobler MR, Radetich B, Zhu Y, Atadja PW, Claiborne T, Grob JE, McRiner A, Pancost MR, Patnaik A, et al. Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors. Bioorg Med Chem. 2011;19(15):4626\u20134634.","journal-title":"Bioorg Med Chem"},{"issue":"3","key":"e_1_3_5_75_1","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/jps.21494","article-title":"Calculation of molecular lipophilicity: State-of-the-art and comparison of log P methods on more than 96,000 compounds","volume":"98","author":"Mannhold R","year":"2009","unstructured":"Mannhold R, Poda GI, Ostermann C, Tetko IV. Calculation of molecular lipophilicity: State-of-the-art and comparison of log P methods on more than 96,000 compounds. J Pharm Sci. 2009;98(3):861\u2013893.","journal-title":"J Pharm Sci"},{"key":"e_1_3_5_76_1","doi-asserted-by":"crossref","first-page":"106207","DOI":"10.1016\/j.bioorg.2022.106207","article-title":"Human dihydrofolate reductase inhibition effect of 1-Phenylpyrazolo [3, 4\u2013d] pyrimidines: Synthesis, antitumor evaluation and molecular modeling study","volume":"129","author":"Salem IM","year":"2022","unstructured":"Salem IM, Mostafa SM, Salama I, El-Sabbagh OI, Hegazy WA, Ibrahim TS. Human dihydrofolate reductase inhibition effect of 1-Phenylpyrazolo [3, 4\u2013d] pyrimidines: Synthesis, antitumor evaluation and molecular modeling study. Bioorg Chem. 2022;129:106207.","journal-title":"Bioorg Chem"},{"issue":"3","key":"e_1_3_5_77_1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/cmdc.200700262","article-title":"The calculation of polar surface area from first principles: An application of quantum chemical topology to drug design","volume":"3","author":"Bytheway I","year":"2008","unstructured":"Bytheway I, Darley MG, Popelier PL. The calculation of polar surface area from first principles: An application of quantum chemical topology to drug design. ChemMedChem: Chemistry Enabling Drug Discovery. 2008;3(3):445\u2013453.","journal-title":"ChemMedChem: Chemistry Enabling Drug Discovery"},{"key":"e_1_3_5_78_1","first-page":"108671","author":"Salem IM","year":"2025","unstructured":"Salem IM, El-Sabbagh OI, Mostafa SM, Salama I, Al-Awadh MA, Alkhilaiwi FA, Yonbawi AR, Binothman N, Hayallah AM, Ibrahim TS. Exploitation of Novel Pyrazolo [3, 4-d] Pyrimidine Scaffold Tethered to Thiazole as Potential EGFR\/HER2 Dual Kinase Inhibitor to Overcome Lapatinib Resistant Breast Cancer: Design, Synthesis, in Silico Docking and Molecular Dynamic Simulation, Bioorg. Chem. 2025;163:108671.","journal-title":"Exploitation of Novel Pyrazolo [3, 4-d] Pyrimidine Scaffold Tethered to Thiazole as Potential EGFR\/HER2 Dual Kinase Inhibitor to Overcome Lapatinib Resistant Breast Cancer: Design, Synthesis, in Silico Docking and Molecular Dynamic Simulation, Bioorg. Chem."},{"issue":"24","key":"e_1_3_5_79_1","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1021\/jacs.6b04088","article-title":"Ni-catalyzed carboxylation of unactivated alkyl chlorides with CO2","volume":"138","author":"B\u00f6rjesson M","year":"2016","unstructured":"B\u00f6rjesson M, Moragas T, Martin R. Ni-catalyzed carboxylation of unactivated alkyl chlorides with CO2. J Am Chem Soc. 2016;138(24):7504\u20137507.","journal-title":"J Am Chem Soc"},{"issue":"1","key":"e_1_3_5_80_1","doi-asserted-by":"crossref","first-page":"15477","DOI":"10.1038\/s41598-025-97395-4","article-title":"Unveiling the potency of ZnO and CuO nanocomposites in combating hepatocellular carcinoma by inducing cell death and suppressing migration","volume":"15","author":"Allam RM","year":"2025","unstructured":"Allam RM, El-Nasr NMA, Elbaset MA, Saleh DO, El-Seidy AM. Unveiling the potency of ZnO and CuO nanocomposites in combating hepatocellular carcinoma by inducing cell death and suppressing migration. Sci Rep. 2025;15(1):15477.","journal-title":"Sci Rep"},{"issue":"3","key":"e_1_3_5_81_1","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s11030-024-11010-8","article-title":"Design, synthesis, and anti-breast cancer activity evaluation of novel 3-cyanopyridine derivatives as PIM-1 inhibitors","volume":"29","author":"Hussein BR","year":"2025","unstructured":"Hussein BR, Mohammed HH, Ahmed EA, Alshazly O, Mohamed MF, Omran OA. Design, synthesis, and anti-breast cancer activity evaluation of novel 3-cyanopyridine derivatives as PIM-1 inhibitors. Mol Divers. 2025;29(3):2565\u20132584.","journal-title":"Mol Divers"},{"key":"e_1_3_5_82_1","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.ijbiomac.2022.10.152","article-title":"L-arginase from Streptomyces diastaticus MAM5 as a potential therapeutic agent in breast cancer: Purification, characterization, G1 phase arrest and autophagy induction","volume":"224","author":"Hassabo AA","year":"2023","unstructured":"Hassabo AA, Abdelraof M, Allam RM. L-arginase from Streptomyces diastaticus MAM5 as a potential therapeutic agent in breast cancer: Purification, characterization, G1 phase arrest and autophagy induction. Int J Biol Macromol. 2023;224:634\u2013645.","journal-title":"Int J Biol Macromol"},{"issue":"9","key":"e_1_3_5_83_1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nchembio.2134","article-title":"Histone deacetylase 6 structure and molecular basis of catalysis and inhibition","volume":"12","author":"Hai Y","year":"2016","unstructured":"Hai Y, Christianson DW. Histone deacetylase 6 structure and molecular basis of catalysis and inhibition. Nat Chem Biol. 2016;12(9):741\u2013747.","journal-title":"Nat Chem Biol"},{"key":"e_1_3_5_84_1","doi-asserted-by":"crossref","first-page":"108181","DOI":"10.1016\/j.bioorg.2025.108181","article-title":"Exploration of anti-inflammatory activity of pyrazolo [3, 4-d] pyrimidine\/1, 2, 4-oxadiazole hybrids as COX-2, 5-LOX and NO release inhibitors: Design, synthesis, in silico and in vivo studies","volume":"156","author":"Aziz MA","year":"2025","unstructured":"Aziz MA, Salem IM, Al-Awadh MA, Alharbi AS, Abouzed DEE, Allam RM, Ahmed OA, Ibrahim TS, Abuo-Rahma GE-DA, Mohamed MF. Exploration of anti-inflammatory activity of pyrazolo [3, 4-d] pyrimidine\/1, 2, 4-oxadiazole hybrids as COX-2, 5-LOX and NO release inhibitors: Design, synthesis, in silico and in vivo studies. Bioorg Chem. 2025;156:108181.","journal-title":"Bioorg Chem"},{"key":"e_1_3_5_85_1","doi-asserted-by":"crossref","first-page":"141504","DOI":"10.1016\/j.molstruc.2025.141504","article-title":"Microwave assisted synthesis, biological assessment and in-silico studies of some new 5, 5\u2032-(phenylmethylene) bisuracil and dihydropyrido [2, 3-d: 6, 5-d\u2019] dipyrimidine derivatives as selective COX-2 inhibitors with potential anti-inflammatory activities","volume":"1331","author":"Hayallah AM","year":"2025","unstructured":"Hayallah AM, Shaaban MA, Abdelrahman MH, Salem IM, Mohamed MF, Elbastawesy MA, Ibrahim TS, Awan ZA, Samir M. Microwave assisted synthesis, biological assessment and in-silico studies of some new 5, 5\u2032-(phenylmethylene) bisuracil and dihydropyrido [2, 3-d: 6, 5-d\u2019] dipyrimidine derivatives as selective COX-2 inhibitors with potential anti-inflammatory activities. J Mol Struct. 2025;1331:141504.","journal-title":"J Mol Struct"},{"issue":"1","key":"e_1_3_5_86_1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13568-025-01835-3","article-title":"Reprofiling lamivudine as an antibiofilm and anti-pathogenic agent against Pseudomonas aeruginosa","volume":"15","author":"Alyahyawy OY","year":"2025","unstructured":"Alyahyawy OY, Munshi RM, Badr-Eldin SM, Aldawsari HM, Abualsunun W, Abbas HA, Salem IM, Hegazy WA, Nazeih SI. Reprofiling lamivudine as an antibiofilm and anti-pathogenic agent against Pseudomonas aeruginosa. AMB Express. 2025;15(1):33.","journal-title":"AMB Express"},{"key":"e_1_3_5_87_1","first-page":"570813","article-title":"Novel Pyrazole-3-Cyano-2-Pyridinone Hybrids as Multitarget Anti-Inflammatory Agents: Synthesis, Computational Modeling, and Biological Evaluation","volume":"20","author":"Hussein BRM","year":"2026","unstructured":"Hussein BRM, Salem IM, Aziz HA, Alshazly O, Hofny HA, Mohassab AM, Awan ZA, Ibrahim TS, Mahmoud EM, Br\u00e4se S, et al. Novel Pyrazole-3-Cyano-2-Pyridinone Hybrids as Multitarget Anti-Inflammatory Agents: Synthesis, Computational Modeling, and Biological Evaluation. Drug Des Devel Ther. 2026;20:570813.","journal-title":"Drug Des Devel Ther"},{"key":"e_1_3_5_88_1","doi-asserted-by":"crossref","first-page":"117891","DOI":"10.1016\/j.ejmech.2025.117891","article-title":"Unveiling ortho-phenolic Mannich ciprofloxacin-chalcone conjugates with potential antineoplastic activity: synthesis, mechanistic study, in silico docking and molecular dynamic simulation","volume":"296","author":"Abdel-Rahman Islam M","year":"2025","unstructured":"Abdel-Rahman, Islam M, Abdel-Aziz, Mohamed, Hassan, Heba Ali, Abu-Baih, Dalia H, Fathy, Moustafa, Salem, Ibrahim M, Ibrahim, Tarek S, Hayallah, Alaa M, Abuo-Rahma, GamalEl-Din A, Mohamed Badr, Unveiling ortho-phenolic Mannich ciprofloxacin-chalcone conjugates with potential antineoplastic activity: synthesis, mechanistic study, in silico docking and molecular dynamic simulation, Eur J Med Chem(2025), 296 117891.","journal-title":"Eur J Med Chem"},{"key":"e_1_3_5_89_1","doi-asserted-by":"crossref","first-page":"108694","DOI":"10.1016\/j.bioorg.2025.108694","article-title":"Synthesis and apoptotic induction of sulfonamide-based chalcone hybrids as first-in-class dual histone deacetylase\u2011carbonic anhydrase inhibitors with potential anti-tubulin activity","volume":"163","author":"Mohamed MF","year":"2025","unstructured":"Mohamed MF, Salem IM, Fouad A, Allam RM, Fadaly WA, Nemr MT, Ewieda SY, Ibrahim TS, Ibrahim NA, Abou-Salim MA. Synthesis and apoptotic induction of sulfonamide-based chalcone hybrids as first-in-class dual histone deacetylase\u2011carbonic anhydrase inhibitors with potential anti-tubulin activity. Bioorg Chem. 2025;163:108694.","journal-title":"Bioorg Chem"},{"issue":"3","key":"e_1_3_5_90_1","doi-asserted-by":"crossref","first-page":"e70101","DOI":"10.1002\/ddr.70101","article-title":"Repurposing nitroimidazoles: a new frontier in combatting bacterial virulence and quorum sensing via in silico, in vitro, and in vivo insights","volume":"86","author":"Khafagy ES","year":"2025","unstructured":"Khafagy ES, Saqr AA, Almutairy BK, Aldawsari MF, Lila ASA, Ibrahim TS, Hegazy WA, Salem IM. Repurposing nitroimidazoles: a new frontier in combatting bacterial virulence and quorum sensing via in silico, in vitro, and in vivo insights. Drug Dev Res. 2025;86(3):e70101.","journal-title":"Drug Dev Res"},{"key":"e_1_3_5_91_1","doi-asserted-by":"crossref","first-page":"109081","DOI":"10.1016\/j.bioorg.2025.109081","article-title":"Pioneering 1, 3, 5-triaryl pyrazolines as promising dual inhibitors of COX-2 and 15-LOX endowed with potent anticancer activity: design, synthesis, and in silico study","volume":"166","author":"Abdullah D","year":"2025","unstructured":"Abdullah D, Baraka MM, Elshanawani AA, El-Sabbagh OI, Salem IM. Pioneering 1, 3, 5-triaryl pyrazolines as promising dual inhibitors of COX-2 and 15-LOX endowed with potent anticancer activity: design, synthesis, and in silico study. Bioorg Chem. 2025;166:109081.","journal-title":"Bioorg Chem"},{"key":"e_1_3_5_92_1","doi-asserted-by":"crossref","first-page":"109591","DOI":"10.1016\/j.bioorg.2026.109591","article-title":"Integrating synthesis, pharmacological evaluation, and molecular dynamics simulation of novel 8-substituted theophylline hybrids as potential PDE-4B inhibitors, bronchodilators and antibacterial","volume":"172","author":"Ali TF","year":"2026","unstructured":"Ali TF, Yani MA, Salem IM, Mamdoh H, Radwan MF, Ibrahim TS, Beshr EA, Hayallah AM. Integrating synthesis, pharmacological evaluation, and molecular dynamics simulation of novel 8-substituted theophylline hybrids as potential PDE-4B inhibitors, bronchodilators and antibacterial. Bioorg Chem. 2026;172:109591.","journal-title":"Bioorg Chem"},{"issue":"2","key":"e_1_3_5_93_1","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.62110\/sciencein.cbl.2026.v13.1761","article-title":"Harnessing dual CA\/EGFR inhibition via pyrazolo [3, 4-d] pyrimidine-nucleobase\/Sulfonamide hybrids: Synthesis, antiproliferative, pro-apoptotic and in silico investigations","volume":"13","author":"Salem I","year":"2026","unstructured":"Salem I, Hayallah A, Elnagar MR, Aboelela A, Abou-Elkhair RA, Al-Awadh MA, Giovannuzzi S, Ibrahim TS, Supuran CT, Mahmoud EM. Harnessing dual CA\/EGFR inhibition via pyrazolo [3, 4-d] pyrimidine-nucleobase\/Sulfonamide hybrids: Synthesis, antiproliferative, pro-apoptotic and in silico investigations. Chem Biol Lett. 2026;13(2):1761\u20131761.","journal-title":"Chem Biol Lett"}],"container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14756366.2026.2711875","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14756366.2026.2711875","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14756366.2026.2711875","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:39:43Z","timestamp":1787888383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14756366.2026.2711875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/14756366.2026.2711875"],"URL":"https:\/\/doi.org\/10.1080\/14756366.2026.2711875","relation":{},"ISSN":["1475-6366","1475-6374"],"issn-type":[{"value":"1475-6366","type":"print"},{"value":"1475-6374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-04-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2711875"}}